Condition: Solid Cancer · Sponsor: Daiichi Sankyo
This study will evaluate the safety and efficacy of R-DXd therapy in participants with ovarian, peritoneal, or fallopian tube cancer.
This description comes directly from the study's public registry record.
Medical Director Contact for Clinical Trial Information · 908-992-6400 · CTRinfo_us@daiichisankyo.com
Always discuss trial participation with your own doctor first.
| Alaska Women's Cancer Care | Anchorage, Alaska, United States | Recruiting |
| Yale University School of Medicine | New Haven, Connecticut, United States | Recruiting |
| Sylvester Comprehensive Cancer Center at Lennar | Coral Gables, Florida, United States | Active Not Recruiting |
| Sylvester Comprehensive Cancer Center at Deerfield Beach | Deerfield Beach, Florida, United States | Active Not Recruiting |
| Florida Cancer Specialists | Lake Mary, Florida, United States | Recruiting |
| Sylvester Cancer Center | Miami, Florida, United States | Recruiting |
| Mount Sinai Comprehensive Cancer Center | Miami Beach, Florida, United States | Recruiting |
| Sylvester Comprehensive Cancer Center at Plantation | Plantation, Florida, United States | Active Not Recruiting |
| Community MD Anderson Cancer Center- East | Indianapolis, Indiana, United States | Active Not Recruiting |
| Community MD Anderson Cancer Center- South | Indianapolis, Indiana, United States | Active Not Recruiting |
| Community Health Network - MD Anderson | Indianapolis, Indiana, United States | Recruiting |
| St. Elizabeth Medical Center | Edgewood, Kentucky, United States | Recruiting |
+ 152 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06161025